Order Article Reprints

Cusato J, Bertani L, Antonucci M, Tomasello C, Caviglia GP, Dibitetto S, Massano A, Mangia M, Mula J, Ceccarelli L, et al. Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study. Pharmaceuticals. 2021; 14(12):1230. https://doi.org/10.3390/ph14121230

Cusato, Jessica, Lorenzo Bertani, Miriam Antonucci, Cristina Tomasello, Gian Paolo Caviglia, Simone Dibitetto, Alessandro Massano, Michela Mangia, Jacopo Mula, Linda Ceccarelli, and et al. 2021. "Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study" Pharmaceuticals 14, no. 12: 1230. https://doi.org/10.3390/ph14121230

Cusato, J., Bertani, L., Antonucci, M., Tomasello, C., Caviglia, G. P., Dibitetto, S., Massano, A., Mangia, M., Mula, J., Ceccarelli, L., Costa, F., Zanzi, F., Astegiano, M., Ribaldone, D. G., & D’Avolio, A. (2021). Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study. Pharmaceuticals, 14(12), 1230. https://doi.org/10.3390/ph14121230